Funding a struggle for Washington life science startups
Funding sources are drying up for life science startups in Washington State - thanks to some tough new legislation and a challenging venture capital environment.
Why venture capitalists bail from funding deals
TechCrunch just posted a list of why deals can fall apart, and why a VC can pull a term sheet. It's written by Jason Lemkin, managing director at Storm Ventures.
Why Pharma Companies Should Look To Social Media For Better Patient Insight
Healthcare decision-makers, especially at pharmaceutical companies, must prioritize patient input. Data collected from social media listening is a significant step in the right direction.